Montrusco Bolton Investments Inc. Raises Stake in Danaher Corporation $DHR

Montrusco Bolton Investments Inc. lifted its stake in shares of Danaher Corporation (NYSE:DHR) by 4.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,789,225 shares of the conglomerate’s stock after purchasing an additional 72,680 shares during the quarter. Danaher accounts for about 3.8% of Montrusco Bolton Investments Inc.’s holdings, making the stock its 9th largest position. Montrusco Bolton Investments Inc.’s holdings in Danaher were worth $345,804,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Hills Bank & Trust Co raised its position in shares of Danaher by 0.3% in the 1st quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate’s stock worth $3,693,000 after acquiring an additional 53 shares in the last quarter. Worth Financial Advisory Group LLC raised its position in shares of Danaher by 4.6% in the 2nd quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock worth $236,000 after acquiring an additional 53 shares in the last quarter. Sageworth Trust Co raised its position in shares of Danaher by 2.3% in the 1st quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate’s stock worth $493,000 after acquiring an additional 54 shares in the last quarter. 1834 Investment Advisors Co. raised its position in shares of Danaher by 3.3% in the 1st quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate’s stock worth $342,000 after acquiring an additional 54 shares in the last quarter. Finally, Bruce G. Allen Investments LLC raised its position in shares of Danaher by 13.1% in the 2nd quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock worth $92,000 after acquiring an additional 54 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

DHR has been the subject of several research reports. Evercore ISI increased their target price on Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Barclays restated an “overweight” rating and issued a $225.00 price target (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Rothschild & Co Redburn restated a “neutral” rating and issued a $220.00 price target (down previously from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Redburn Partners set a $220.00 price target on Danaher in a research note on Wednesday. Finally, Royal Bank Of Canada set a $241.00 price target on Danaher in a research note on Tuesday, September 2nd. Seventeen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average target price of $244.60.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Performance

Shares of DHR opened at $202.53 on Monday. The business’s fifty day simple moving average is $200.66 and its two-hundred day simple moving average is $197.07. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.41. The company has a market cap of $145.02 billion, a price-to-earnings ratio of 43.09, a P/E/G ratio of 2.88 and a beta of 0.77.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same period last year, the business posted $1.72 EPS. The company’s revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.